CSIR, the country's premier research organisation, is aiming to tap the multi-million- dollar Intellectual property rights market by commercialising its patents and leasing it to different industrial bodies, including drug makers.
Council for Scientific and Industrial Research, which has around 38 research and development laboratories across the country, is mulling to commercialise its patent system, and going a step further, the organisation is planning to tie up with some professional bodies.
"We are working on the different models (of patent business) to commercialise our patent system, which has a huge potential to become a good source of income for the organisation," CSIR Director General Samir K Brahmachari told .
Headed by the Prime Minister, CSIR is one of the world's largest publicly funded R&D organisations and it has linkages with academia, R&D organisations and industry. Prime Minister of India is the ex-officio President of CSIR.
CSIR, an autonomous body set up through the acts of the parliament is aiming to tap the billion-dollar markets from its innovations by leasing its patents to the potential buyers like drug manufactures and other industrial bodies.
When asked about the volume of patent granted and number of patent application, he said that CSIR was one of the biggest application filer in the country.
However, he also admitted that some of their patents were not up to the level.
CSIR generates a number of the inventions annually but the quality of these innovations is not so high, which is a matter of concern for the authorities.
Top Section
Explore Business Standard